US OptionsDetailed Quotes

JANX250117P50000

Watchlist

4.00
+2.35+142.42%

15min DelayClose Jan 8 16:00 ET

4.00High1.80Low

Janux Therapeutics Stock Discussion

Kevin Travers

Dec 3, 2024 15:20

Columns Fresh Closing Highs from S&P 500 and Nasdaq | Wall Street Today

After pulling back during the day, the S&P 500 and Nasdaq hit fresh closing highs- and the Nasdaq hit a trading high of 19,486.15.
Just past 4 pm ET the $S&P 500 Index (.SPX.US)$ climbed 0.05%, the $Dow Jones Industrial Average (.DJI.US)$ fell 0.17%, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 0.40%.
MACRO
JOLTS job openings from the Bureau of Labor Statistics came in at 7.74M, higher than last month's number, but ever since Ap...

Market eyes Non-Farm data: Will there be a rate cut in Dec?

Rivera

Dec 2, 2024 15:50

Up up

$Janux Therapeutics (JANX.US)$

Stock_Drift

Dec 2, 2024 15:45

After Hours Ticks 5:44pm 12/2

$CytomX (CTMX.US)$ $Onconetix (ONCO.US)$ $Edesa Biotech (EDSA.US)$ $XBP Europe Holdings (XBP.US)$ $Nauticus Robotics (KITT.US)$ $Alset (AEI.US)$ $Carmell (CTCX.US)$ $Jayud Global Logistics Ltd. (JYD.US)$ $Vir Biotechnology (VIR.US)$ $Shimmick (SHIM.US)$ $Credo Technology (CRDO.US)$ $Janux Therapeutics (JANX.US)$ $Citius Oncology (CTOR.US)$ $Volato Group (SOAR.US)$
📊⚡️📊

103280143

Nov 18, 2024 07:51

A Glimpse into My 2025 Stock Picks (US Edition)

As we enter 2025, the U.S. stock market presents a landscape ripe with opportunities. The Federal Reserve's recent meeting minutes indicate a cautious yet optimistic approach, suggesting that while inflationary pressures are being monitored, the overall economic outlook remains positive. This balanced stance bodes well for investors seeking growth in the coming year.
Janux Therapeutics Inc. (NASDAQ: JANX)
Janux Therapeutics is a clinical-stage bioph...

Powell says no hurry for Fed rate cuts, how will you adjust your investment strategy?

SpeedyStud

Nov 17, 2024 18:33

Mid Month Update

Hey everyone! Like I mentioned in the last post, the big news is that MoomooCA has set up a server for me, and it's open for all of you to join! It’s called Trader’s Tavern, and yes—the profile pic is my cat <3
In there, I’ll be sharing more in-depth stock analysis, including entry and target points, plus detailed descriptions of each stock. It’d be great if you all could join us there!
In the meantime, here’s our mid-month update on some stocks I’m keeping an eye on! Let’s aim f...

Shaaaw

Jun 25, 2024 07:07

Here’s why I think that $MRK buys $JANX soon.

$Merck & Co (MRK.US)$ on the prowl for acquisitions up to $15 billion.
$Merck & Co (MRK.US)$ already has an active partnership with $Janux Therapeutics (JANX.US)$ for two TRACtr targets, and CEO Davis has evinced a preference for acquisition of $SPDR S&P Biotech ETF (XBI.US)$ in which $Merck & Co (MRK.US)$ already has a seat at the table.
$Merck & Co (MRK.US)$ acquisition of $HARP earlier this year (for a song) shows their interest in the T Cell engag...